Unknown

Dataset Information

0

Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.


ABSTRACT: Although antiviral drugs are available for the treatment of influenza infection, it is an urgent requirement to develop new antiviral drugs regarding the emergence of drug-resistant viruses. The nucleoprotein (NP) is conserved among all influenza A viruses (IAVs) and has no cellular equivalent. Therefore, NP is an ideal target for the development of new IAV inhibitors. In this study, we identified a novel anti-influenza compound, ZBMD-1, from a library of 20,000 compounds using cell-based influenza A infection assays. We found that ZBMD-1 inhibited the replication of H1N1 and H3N2 influenza A virus strains in vitro, with an IC50 ranging from 0.41-1.14 ?M. Furthermore, ZBMD-1 inhibited the polymerase activity and specifically impaired the nuclear export of NP. Further investigation indicated that ZBMD-1 binds to the nuclear export signal 3 (NES3) domain and the dimer interface of the NP pocket. ZBMD-1 also protected mice that were challenged with lethal doses of A/PR/8/1934 (H1N1) virus, effectively relieving lung histopathology changes, as well as strongly inhibiting the expression of pro-inflammatory cytokines/chemokines, without inducing toxicity effects in mice. These results suggest that ZBMD-1 is a promising anti-influenza compound which can be further investigated as a useful strategy against IAVs in the future.

SUBMITTER: Huang F 

PROVIDER: S-EPMC5824420 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.

Huang Feng F   Chen Jingliang J   Zhang Junsong J   Tan Likai L   Lu Gui G   Luo Yongjie Y   Pan Ting T   Liang Juanran J   Li Qianwen Q   Luo Baohong B   Zhang Hui H   Lu Gen G  

Journal of cellular and molecular medicine 20171130 3


Although antiviral drugs are available for the treatment of influenza infection, it is an urgent requirement to develop new antiviral drugs regarding the emergence of drug-resistant viruses. The nucleoprotein (NP) is conserved among all influenza A viruses (IAVs) and has no cellular equivalent. Therefore, NP is an ideal target for the development of new IAV inhibitors. In this study, we identified a novel anti-influenza compound, ZBMD-1, from a library of 20,000 compounds using cell-based influe  ...[more]

Similar Datasets

| S-EPMC3347336 | biostudies-literature
| S-EPMC11321118 | biostudies-literature
| S-EPMC7111614 | biostudies-literature
| S-EPMC4519322 | biostudies-literature
| S-EPMC6692485 | biostudies-literature
| S-EPMC7117665 | biostudies-literature
| S-EPMC7113721 | biostudies-literature
| S-EPMC4548311 | biostudies-literature
| S-EPMC4442427 | biostudies-literature
| S-EPMC10786660 | biostudies-literature